Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients
Status:
Terminated
Trial end date:
2019-04-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn if using a Entocort (budesonide) to treat diarrhea will
be effective and safe for kidney transplant patients, allowing them to continue with MPA
medication.